Effects of COVID-19 on Respiratory System

被引:0
作者
Karahalil, Bensu [1 ]
Deniz, Muhammed Ercan [1 ]
Iyigundogdu, Irem [1 ]
Tumer, Miray [1 ]
机构
[1] Gazi Univ, Fac Pharm, Dept Pharmaceut Toxicol, Ankara, Turkey
来源
GAZI MEDICAL JOURNAL | 2020年 / 31卷 / 3A期
关键词
COVID-19; viral entry; ACE2; receptor; respiratory system; SARS-CoV; ARDS; CORONAVIRUS;
D O I
10.12996/gmj.2020.124
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronavirus disease 2019 (COVID-19) was caused by a novel type of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was originated in Wuhan, China in December 2019. It spreads rapidly all over the world since respiratory virus infection can occur through many easy ways (e.g. contact, droplet spray, aerosol) and besides, asymptomatic people also have contagiousness. So far, there have been 23,491,520 confirmed cases of COVID-19, including 809,970 deaths, reported to World Health Organization (WHO), which declared it as a significant threat to global health. Fever, fatigue, and dry cough are the commonly observed symptoms in the patients. In COVID-19, the main affected system is respiratory system and some cases demonstrate a rapid progression to acute respiratory distress syndrome (ARDS), while other organs are less involved. Angiotensin-converting enzyme 2 receptor-virus association is essential and responsible for the development of the disease. SARS-CoV-2 causes deaths through its severe effects on the respiratory system.
引用
收藏
页码:528 / 531
页数:4
相关论文
共 25 条
[1]  
Andersen B.M., 2019, Protection of Upper Respiratory Tract, Mouth and Eyes, P129
[2]  
Anesi G., 2019, Coronavirus disease 2019 (covid-19): Critical care and airway management issues
[3]  
[Anonymous], 2020, REPORT WHO CHINA JOI
[4]  
Cascella M, 2020, Features, Evaluation, And Treatment of Coronavirus (COVID-19)
[5]  
Cohen P., 2020, LIT REV CURRENT
[6]  
Control Disease Center (CDC), FACT SHEET SARS PAT
[7]   The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system [J].
Coperchini, Francesca ;
Chiovato, Luca ;
Croce, Laura ;
Magri, Flavia ;
Rotondi, Mario .
CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 53 :25-32
[8]   COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options [J].
Guzik, Tomasz J. ;
Mohiddin, Saidi A. ;
Dimarco, Anthony ;
Patel, Vimal ;
Savvatis, Kostas ;
Marelli-Berg, Federica M. ;
Madhur, Meena S. ;
Tomaszewski, Maciej ;
Maffia, Pasquale ;
D'Acquisto, Fulvio ;
Nicklin, Stuart A. ;
Marian, Ali J. ;
Nosalski, Ryszard ;
Murray, Eleanor C. ;
Guzik, Bartlomiej ;
Berry, Colin ;
Touyz, Rhian M. ;
Kreutz, Reinhold ;
Wang, Dao Wen ;
Bhella, David ;
Sagliocco, Orlando ;
Crea, Filippo ;
Thomson, Emma C. ;
McInnes, Iain B. .
CARDIOVASCULAR RESEARCH, 2020, 116 (10) :1666-1687
[9]   Coronavirus disease 2019 (COVID-19): A literature review [J].
Harapan, Harapan ;
Itoh, Naoya ;
Yufika, Amanda ;
Winardi, Wira ;
Keam, Synat ;
Te, Haypheng ;
Megawati, Dewi ;
Hayati, Zinatul ;
Wagner, Abram L. ;
Mudatsir, Mudatsir .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (05) :667-673
[10]   Cellular entry of the SARS coronavirus [J].
Hofmann, H ;
Pöhlmann, S .
TRENDS IN MICROBIOLOGY, 2004, 12 (10) :466-472